Page 75 - Demo
P. 75
www.psypharma.ru %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430 %u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430 %u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432 %u2116 4/2024%u041f%u0435%u0442%u0435%u043b%u0438%u043d %u0414.%u0421., %u0410%u0432%u0435%u0434%u0438%u0441%u043e%u0432%u0430 %u0410.%u0421. %u0438 %u0434%u0440.75%u041f%u0420%u0410%u041a%u0422%u0418%u041a%u041038. Bloch M.H., McGuire J., Landeros-Weisenberger A., Leckman J.F., Pittenger C. Metaanalysis of the dose-response relationship of SSRI in obsessive-compulsive disorder // Molecular Psychiatry. %u2013 2010. %u2013 Vol. 15 (8). %u2013 Pp. 850%u2013855. %u2013 https://doi.org/10.1038/mp.2009.5038. Bloch M.H., McGuire J., Landeros-Weisenberger A., Leckman J.F., Pittenger C. Metaanalysis of the dose-response relationship of SSRI in obsessive-compulsive disorder // Molecular Psychiatry. %u2013 2010. %u2013 Vol. 15 (8). %u2013 Pp. 850%u2013855. %u2013 https://doi.org/10.1038/mp.2009.5039. American Psychiatric Association (APA). Practice guideline for obsessive-compulsive disorder, 2007. %u2013 Available at: https://psychia-tryonline.org/guideline (accessed October 4, 2024).39. American Psychiatric Association (APA). Practice guideline for obsessive-compulsive disorder, 2007. %u2013 Available at: https://psychia-tryonline.org/guideline (accessed October 4, 2024).40. %u0420%u043e%u0441%u0441%u0438%u0439%u0441%u043a%u043e%u0435 %u043e%u0431%u0449%u0435%u0441%u0442%u0432%u043e %u043f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u043e%u0432. %u041a%u043b%u0438%u043d%u0438%u0447%u0435%u0441%u043a%u0438%u0435 %u0440%u0435%u043a%u043e%u043c%u0435%u043d%u0434%u0430%u0446%u0438%u0438. %u041e%u0431%u0441%u0435%u0441%u0441%u0438%u0432%u043d%u043e-%u043a%u043e%u043c%u043f%u0443%u043b%u044c%u0441%u0438%u0432%u043d%u043e%u0435 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432%u043e, 2019. %u2013 URL: https://psychiatr.ru/download/4318?view=1&name=%D0%9A%D0%A0+%D0%9E%D0%9A%D0%A0.pdf (accessed October 4, 2024).40. Rossijskoe obshhestvo psihiatrov. Klinicheskie rekomendacii. Obsessivno-kompul%u2019sivnoe rasstrojstvo, 2019. %u2013 URL: https://psychiatr.ru/download/4318?view=1&name=%D0%9A%D0%A0+%D0%9E%D0%9A%D0%A0.pdf (accessed October 4, 2024).41. Ninan%u00df P.T., Koran L.M., Kiev A. et al. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial // The Journal of Clinical Psychiatry. %u2013 2006. %u2013 Vol. 67 (1). %u2013 Pp. 15%u201322. %u2013 https://doi.org/10.4088/jcp.v67n010341. Ninan%u00df P.T., Koran L.M., Kiev A. et al. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial // The Journal of Clinical Psychiatry. %u2013 2006. %u2013 Vol. 67 (1). %u2013 Pp. 15%u201322. %u2013 https://doi.org/10.4088/jcp.v67n010342. Issari Y. et al. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis // The Journal of Clinical Psychiatry. %u2013 2016. %u2013 Vol. 77 (5). %u2013 Pp. e605%u2013e611.42. Issari Y. et al. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis // The Journal of Clinical Psychiatry. %u2013 2016. %u2013 Vol. 77 (5). %u2013 Pp. e605%u2013e611.43. Brar J., Sidana A., Chauhan N., Bajaj M.K. Effect of sertraline and fluvoxamine on quality of life in patients with obsessive-compulsive disorder: A 12-week interventional study // Industrial Psychiatry Journal. %u2013 2022. %u2013 Vol. 31 (1). %u2013 Pp. 26%u201330. %u2013 https://doi.org/10.4103/ipj.ipj_133_2143. Brar J., Sidana A., Chauhan N., Bajaj M.K. Effect of sertraline and fluvoxamine on quality of life in patients with obsessive-compulsive disorder: A 12-week interventional study // Industrial Psychiatry Journal. %u2013 2022. %u2013 Vol. 31 (1). %u2013 Pp. 26%u201330. %u2013 https://doi.org/10.4103/ipj.ipj_133_2144. %u0410%u0432%u0435%u0434%u0438%u0441%u043e%u0432%u0430 %u0410.%u0421., %u0410%u0445%u0430%u043f%u043a%u0438%u043d %u0420.%u0412. %u041f%u0440%u043e%u0431%u043b%u0435%u043c%u044b %u043a%u043b%u0438%u043d%u0438%u0447%u0435%u0441%u043a%u043e%u0439 %u043e%u0446%u0435%u043d%u043a%u0438 %u043f%u0435%u0440%u0435%u043d%u043e%u0441%u0438%u043c%u043e%u0441%u0442%u0438 %u0442%u0435%u0440%u0430%u043f%u0438%u0438 %u043f%u0441%u0438%u0445%u043e%u0442%u0440%u043e%u043f%u043d%u044b%u043c%u0438 %u043f%u0440%u0435%u043f%u0430%u0440%u0430%u0442%u0430%u043c%u0438 // %u041f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u044f %u0438 %u043f%u0441%u0438%u0445%u043e%u0444%u0430%u0440%u043c%u0430%u043a%u043e%u0442%u0435%u0440%u0430%u043f%u0438%u044f. %u2013 2005. %u2013 %u0422. 7, %u2116 1. %u2013 %u0421. 17%u201320.44. Avedisova A.S., Ahapkin R.V. Problemy klinicheskoj ocenki perenosimosti terapii psihotropnymi preparatami // Psihiatrija i psihofarmakoterapija. %u2013 2005. %u2013 T. 7, %u2116 1. %u2013 S. 17%u201320.45. Niarchou E., Roberts L.H., Naughton B.D. What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review // Journal of Psychopharmacology. %u2013 2024. %u2013 Vol. 38 (2). %u2013 Pp. 127%u2013136. %u2013 https://doi.org/10.1177/0269881123122417145. Niarchou E., Roberts L.H., Naughton B.D. What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review // Journal of Psychopharmacology. %u2013 2024. %u2013 Vol. 38 (2). %u2013 Pp. 127%u2013136. %u2013 https://doi.org/10.1177/0269881123122417146. Edinoff A.N., Akuly H.A., Hanna T.A. et al. Selective Serotonin reuptake inhibitors and adverse effects: A narrative review // Neurology International. %u2013 2021. %u2013 Vol. 13 (3). %u2013 Pp. 387%u2013401. %u2013 https://doi.org/10.3390/neurolint1303003846. Edinoff A.N., Akuly H.A., Hanna T.A. et al. Selective Serotonin reuptake inhibitors and adverse effects: A narrative review // Neurology International. %u2013 2021. %u2013 Vol. 13 (3). %u2013 Pp. 387%u2013401. %u2013 https://doi.org/10.3390/neurolint1303003847. %u0421%u0430%u043b%u0430%u0445%u043e%u0432%u0430 %u0410.%u0418., %u042f%u0433%u0443%u0431%u043e%u0432 %u041c.%u0418. %u0421%u0435%u043a%u0441%u0443%u0430%u043b%u044c%u043d%u0430%u044f %u0434%u0438%u0441%u0444%u0443%u043d%u043a%u0446%u0438%u044f %u043f%u0440%u0438 %u043f%u0440%u0438%u043c%u0435%u043d%u0435%u043d%u0438%u0438 %u0430%u043d%u0442%u0438%u0434%u0435%u043f%u0440%u0435%u0441%u0441%u0430%u043d%u0442%u043e%u0432 %u0443 %u043f%u0430%u0446%u0438%u0435%u043d%u0442%u043e%u0432 %u0441 %u0442%u0440%u0435%u0432%u043e%u0436%u043d%u044b%u043c%u0438 %u0438 %u0434%u0435%u043f%u0440%u0435%u0441%u0441%u0438%u0432%u043d%u044b%u043c%u0438 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432%u0430%u043c%u0438 (%u0430%u043b%u0433%u043e%u0440%u0438%u0442%u043c %u0432%u0435%u0434%u0435%u043d%u0438%u044f %u0438 %u043a%u043e%u0440%u0440%u0435%u043a%u0446%u0438%u0438) // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2024. %u2013 %u2116 2. %u2013 %u0421. 56%u201367. %u2013 https.//doi.org/10.21265/PSYPH.2024.31.31.00647. Salahova A.I., Jagubov M.I. Seksual%u2019naja disfunkcija pri primenenii antidepressantov u pacientov s trevozhnymi i depressivnymi rasstrojstvami (algoritm vedenija i korrekcii) // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2024. %u2013 %u2116 2. %u2013 S. 56%u201367. %u2013 https.//doi.org/10.21265/PSYPH.2024.31.31.00648. %u0410%u0432%u0435%u0434%u0438%u0441%u043e%u0432%u0430 %u0410.%u0421. %u041f%u043e%u0431%u043e%u0447%u043d%u044b%u0435 %u044d%u0444%u0444%u0435%u043a%u0442%u044b %u0430%u043d%u0442%u0438%u0434%u0435%u043f%u0440%u0435%u0441%u0441%u0430%u043d%u0442%u043e%u0432, %u043d%u0430%u0440%u0443%u0448%u0430%u044e%u0449%u0438%u0435 %u0441%u0435%u043a%u0441%u0443%u0430%u043b%u044c%u043d%u044b%u0435 %u0444%u0443%u043d%u043a%u0446%u0438%u0438 // %u041f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u044f %u0438 %u043f%u0441%u0438%u0445%u043e%u0444%u0430%u0440%u043c%u0430%u043a%u043e%u0442%u0435%u0440%u0430%u043f%u0438%u044f. %u2013 2005. %u2013 %u0422. 7, %u2116 6. %u2013 %u0421. 322%u2013329.48. Avedisova A.S. Pobochnye jeffekty antidepressantov, narushajushhie seksual%u2019nye funkcii // Psihiatrija i psihofarmakoterapija. %u2013 2005. %u2013 T. 7, %u2116 6. %u2013 S. 322%u2013329.49. Serretti A., Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis // Journal of Clinical Psychopharmacology. %u2013 2009. %u2013 Vol. 29 (3). %u2013 Pp. 259%u2013266. %u2013 https://doi.org/10.1097/JCP.0b013e3181a5233f49. Serretti A., Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis // Journal of Clinical Psychopharmacology. %u2013 2009. %u2013 Vol. 29 (3). %u2013 Pp. 259%u2013266. %u2013 https://doi.org/10.1097/JCP.0b013e3181a5233f50. Kasper S., Heiden A. Do SSRIs differ in their antidepressant efficacy // Human psychopharmacology. %u2013 1996. %u2013 Vol. 10 (3). %u2013 Pp. S163%u2013S172. %u2013 https://doi.org/10.1002/hup.47010090550. Kasper S., Heiden A. Do SSRIs differ in their antidepressant efficacy // Human psychopharmacology. %u2013 1996. %u2013 Vol. 10 (3). %u2013 Pp. S163%u2013S172. %u2013 https://doi.org/10.1002/hup.47010090551. Sunami E., Usuda K., Nishiyama Y., Otori T., Katsura K., Katayama Y. A Preliminary study of Fluvoxamine Maleate on depressive state and Serum Melatonin levels in patients after cerebral infarction // Internal Medicine. %u2013 2012. %u2013 Vol. 51 (10). %u2013 Pp. 1187%u20131193. %u2013 https://doi.org/10.2169/internalmedicine.51.669951. Sunami E., Usuda K., Nishiyama Y., Otori T., Katsura K., Katayama Y. A Preliminary study of Fluvoxamine Maleate on depressive state and Serum Melatonin levels in patients after cerebral infarction // Internal Medicine. %u2013 2012. %u2013 Vol. 51 (10). %u2013 Pp. 1187%u20131193. %u2013 https://doi.org/10.2169/internalmedicine.51.669952. Hao Y., et al. The Effect of fluvoxamine on sleep architecture of depressed patients with insomnia: An 8-week, open-label, baseline-controlled study // Nature and Science of Sleep. %u2013 2019. %u2013 Vol. 11. %u2013 Pp. 291%u2013300. %u2013 https://doi.org/10.2147/NSS.S220947.52. Hao Y., et al. The Effect of fluvoxamine on sleep architecture of depressed patients with insomnia: An 8-week, open-label, baseline-controlled study // Nature and Science of Sleep. %u2013 2019. %u2013 Vol. 11. %u2013 Pp. 291%u2013300. %u2013 https://doi.org/10.2147/NSS.S220947.53. Pompili M., Serafini G., Innamorati M. et al. Antidepressants and suicide risk: A comprehensive overview // Pharmaceuticals (Basel). %u2013 2010. %u2013 Vol. 3 (9). %u2013 Pp. 2861%u20132883. %u2013 https://doi.org/10.3390/ph309286153. Pompili M., Serafini G., Innamorati M. et al. Antidepressants and suicide risk: A comprehensive overview // Pharmaceuticals (Basel). %u2013 2010. %u2013 Vol. 3 (9). %u2013 Pp. 2861%u20132883. %u2013 https://doi.org/10.3390/ph309286154. Lagerberg T., Fazel S., Sj%u00f6lander A. et al. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study // Neuropsychopharmacology. %u2013 2022. %u2013 Vol. 47. %u2013 Pp. 817%u2013823. %u2013 https://doi.org/10.1038/s41386-021-01179-z54. Lagerberg T., Fazel S., Sj%u00f6lander A. et al. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study // Neuropsychopharmacology. %u2013 2022. %u2013 Vol. 47. %u2013 Pp. 817%u2013823. %u2013 https://doi.org/10.1038/s41386-021-01179-z55. Modarresi A., Chaibakhsh S., Koulaeinejad N., Koupaei S.R. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder // Psychiatry research. %u2013 2019. %u2013 Vol. 282. %u2013 Art. 112602. %u2013 https://doi.org/10.1016/j.psychres.2019.11260255. Modarresi A., Chaibakhsh S., Koulaeinejad N., Koupaei S.R. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder // Psychiatry research. %u2013 2019. %u2013 Vol. 282. %u2013 Art. 112602. %u2013 https://doi.org/10.1016/j.psychres.2019.11260256. Dwyer J.B., Bloch M.H. Antidepressants for pediatric patients // Current Psychiatry. %u2013 2019. %u2013 Vol. 18 (9). %u2013 Pp. 26%u201342F.56. Dwyer J.B., Bloch M.H. Antidepressants for pediatric patients // Current Psychiatry. %u2013 2019. %u2013 Vol. 18 (9). %u2013 Pp. 26%u201342F.57. %u0426%u0443%u043a%u0430%u0440%u0437%u0438 %u042d.%u042d. %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u044b%u0435 %u043c%u0435%u0442%u043e%u0434%u044b %u0441%u0442%u0438%u043c%u0443%u043b%u044f%u0446%u0438%u0438 %u043c%u043e%u0437%u0433%u0430: %u0434%u043e%u0441%u0442%u0438%u0436%u0435%u043d%u0438%u044f %u0438 %u043f%u0435%u0440%u0441%u043f%u0435%u043a%u0442%u0438%u0432%u044b %u043f%u0440%u0438%u043c%u0435%u043d%u0435%u043d%u0438%u044f // %u0421%u043e%u0446%u0438%u0430%u043b%u044c%u043d%u0430%u044f %u0438 %u043a%u043b%u0438%u043d%u0438%u0447%u0435%u0441%u043a%u0430%u044f %u043f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u044f. %u2013 2013. %u2013 %u0422. 23, %u2116 1. %u2013 %u0421. 93%u201399.57. Cukarzi Je.Je. Sovremennye metody stimuljacii mozga: dostizhenija i perspektivy primenenija // Social%u2019naja i klinicheskaja psihiatrija. %u2013 2013. %u2013 T. 23, %u2116 1. %u2013 S. 93%u201399.58. %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d., %u0426%u0443%u043a%u0430%u0440%u0437%u0438 %u042d.%u042d., %u041c%u0430%u0441%u043b%u0435%u043d%u0438%u043a%u043e%u0432 %u041d.%u0412. %u041f%u0440%u0438%u043c%u0435%u043d%u0435%u043d%u0438%u0435 %u0442%u0440%u0430%u043d%u0441%u043a%u0440%u0430%u043d%u0438%u0430%u043b%u044c%u043d%u043e%u0439 %u043c%u0430%u0433%u043d%u0438%u0442%u043d%u043e%u0439 %u0441%u0442%u0438%u043c%u0443%u043b%u044f%u0446%u0438%u0438 %u0432 %u043f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u0438 / %u043f%u043e%u0434 %u0440%u0435%u0434. %u0421.%u041d. %u041c%u043e%u0441%u043e%u043b%u043e%u0432%u0430. %u2013 %u0418%u0432%u0430%u043d%u043e%u0432%u043e: %u041d%u0435%u0439%u0440%u043e%u0441%u043e%u0444%u0442, 2023. %u2013 576 %u0441. 58. Mosolov S.N., Cukarzi Je.Je., Maslenikov N.V. Primenenie transkranial%u2019noj magnitnoj stimuljacii v psihiatrii / pod red. S.N. Mosolova. %u2013 Ivanovo: Nejrosoft, 2023. %u2013 576 s. 59. Mar-Barrutia L., Real E., Segal%u00e1s C. et al. Deep brain stimulation for obsessive-compulsive disorder: A systematic review of worldwide experience after 20 years // World Journal of Psychiatry. %u2013 2021. %u2013 Vol. 11 (9). %u2013 Pp. 659%u2013680. %u2013 https://doi.org/10.5498/wjp.v11.i9.65959. Mar-Barrutia L., Real E., Segal%u00e1s C. et al. Deep brain stimulation for obsessive-compulsive disorder: A systematic review of worldwide experience after 20 years // World Journal of Psychiatry. %u2013 2021. %u2013 Vol. 11 (9). %u2013 Pp. 659%u2013680. %u2013 https://doi.org/10.5498/wjp.v11.i9.65960. Kim C.H., Chang J.W., Koo M.S. et al. Anterior cingulotomy for refractory obsessive-compulsive disorder // Acta psychiatrica Scandinavica. %u2013 2003. %u2013 Vol. 107 (4). %u2013 Pp. 283%u2013290. %u2013 https://doi.org/10.1034/j.1600-0447.2003.00087.x60. Kim C.H., Chang J.W., Koo M.S. et al. Anterior cingulotomy for refractory obsessive-compulsive disorder // Acta psychiatrica Scandinavica. %u2013 2003. %u2013 Vol. 107 (4). %u2013 Pp. 283%u2013290. %u2013 https://doi.org/10.1034/j.1600-0447.2003.00087.x61. Galkin M.V., Zaitsev O.S., Golanov A.V. et al. Gamma Knife capsulotomy for correction of obsessive-compulsive symptoms in a patient with schizophrenia: Case report // Progress in Brain Research. %u2013 2022. %u2013 Vol. 272 (1). %u2013 Pp. 23%u201331. %u2013 https://doi.org/10.1016/bs.pbr.2022.03.01261. Galkin M.V., Zaitsev O.S., Golanov A.V. et al. Gamma Knife capsulotomy for correction of obsessive-compulsive symptoms in a patient with schizophrenia: Case report // Progress in Brain Research. %u2013 2022. %u2013 Vol. 272 (1). %u2013 Pp. 23%u201331. %u2013 https://doi.org/10.1016/bs.pbr.2022.03.01262. Eddy K.T., Dutra L., Bradley R., Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder // Clinical Psychology Review. %u2013 2004. %u2013 Vol. 24 (8). %u2013 Pp. 1011%u20131030. %u2013 https://doi.org/10.1016/j.cpr.2004.08.00462. Eddy K.T., Dutra L., Bradley R., Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder // Clinical Psychology Review. %u2013 2004. %u2013 Vol. 24 (8). %u2013 Pp. 1011%u20131030. %u2013 https://doi.org/10.1016/j.cpr.2004.08.00463. %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d., %u0410%u043b%u0444%u0438%u043c%u043e%u0432 %u041f.%u0412. %u0410%u043b%u0433%u043e%u0440%u0438%u0442%u043c %u0431%u0438%u043e%u043b%u043e%u0433%u0438%u0447%u0435%u0441%u043a%u043e%u0439 %u0442%u0435%u0440%u0430%u043f%u0438%u0438 %u043e%u0431%u0441%u0435%u0441%u0441%u0438%u0432%u043d%u043e-%u043a%u043e%u043c%u043f%u0443%u043b%u044c%u0441%u0438%u0432%u043d%u043e%u0433%u043e %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432%u0430 // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2013. %u2013 %u2116 1. %u2013 C. 41%u201344.63. Mosolov S.N., Alfimov P.V. Algoritm biologicheskoj terapii obsessivno-kompul%u2019sivnogo rasstrojstva // Sovremennaa Terapia Psihiceskih Rasstrojstv.%u2013 2013. %u2013 %u2116 1. %u2013 C. 41%u201344.64. %u0423%u0441%u043e%u0432 %u0413.%u041c. %u0424%u0430%u0440%u043c%u0430%u043a%u043e%u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043e%u0431%u0441%u0435%u0441%u0441%u0438%u0432%u043d%u043e-%u043a%u043e%u043c%u043f%u0443%u043b%u044c%u0441%u0438%u0432%u043d%u043e%u0433%u043e %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432%u0430: %u0444%u043e%u043a%u0443%u0441 %u043d%u0430 %u0444%u043b%u0443%u0432%u043e%u043a%u0441%u0430%u043c%u0438%u043d (%u043e%u0431%u0437%u043e%u0440 %u043b%u0438%u0442%u0435%u0440%u0430%u0442%u0443%u0440%u044b) // %u041f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u044f %u0438 %u043f%u0441%u0438%u0445%u043e%u0444%u0430%u0440%u043c%u0430%u043a%u043e%u0442%u0435%u0440%u0430%u043f%u0438%u044f. %u2013 2020. %u2013 %u2116 4. %u2013 %u0421. 7%u201313. 64. Usov G.M. Farmakoterapija obsessivno-kompul%u2019sivnogo rasstrojstva: fokus na fluvoksamin (obzor literatury) // Psihiatrija i psihofarmakoterapija. %u2013 2020. %u2013 %u2116 4. %u2013 %u0421. 7%u201313.
